A54.02
Gonococcal vulvovaginitis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Gonococcal vulvovaginitis (ICD-10 code A54.02) is an infection of the vulva and vagina caused by the bacteria Neisseria gonorrhoeae. While gonorrhea commonly affects the cervix and other reproductive organs, it can also infect the vulva and vagina, leading to discomfort and inflammation. This condition is usually transmitted through sexual contact and requires appropriate medical treatment to prevent complications and transmission to others. Recognizing the symptoms and understanding the causes and treatment options can help manage this infection effectively.
Causes & Symptoms
Clinical Causes: Infection with the bacteria Neisseria gonorrhoeae, primarily through sexual contact with an infected person. Exposure to contaminated bodily fluids during unprotected sex. Having multiple sexual partners increases the risk of infection. Engaging in sexual activities without barrier protection such as condoms. Sharing contaminated towels, clothing, or bedding (though less common).
Key Symptoms: Unusual vaginal discharge that may be thick, yellow, or greenish. Pain or a burning sensation during urination. Itching, irritation, or soreness around the vulva. Vaginal or vulvar redness and swelling. Discomfort or pain during sexual intercourse. In some cases, no symptoms are present, especially in the early stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a healthcare provider performing a pelvic examination and collecting samples of vaginal discharge or other relevant specimens. Laboratory tests, such as nucleic acid amplification tests (NAATs), are commonly used to detect Neisseria gonorrhoeae. In some cases, culture or microscopy may also be performed. Accurate detection is crucial for effective treatment and preventing further transmission.
Treatment Protocols: Gonococcal vulvovaginitis is generally treated with a course of antibiotics prescribed by a healthcare provider. The current standard treatment involves single-dose antibiotics such as ceftriaxone, often paired with azithromycin to address potential co-infections like chlamydia. It's important to complete the full prescribed course and avoid sexual activity until cleared. Partners should also be notified, tested, and treated if necessary to prevent re-infection and further spread of the bacteria.
Clinical Advice & FAQs
Billing Guidance
Is A54.02 a billable ICD-10 code?
Yes, A54.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A54.02?
Clinical documentation must specify the nature of Gonococcal vulvovaginitis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference